Also, recent studies have associated the presence of cytoplasmic Met determined by IHC with tumor progression in patients with resected bladder cancer [51] and with poor outcome in patients with gastric adenocarcinoma [27] and mesothelioma [50]. The gene discussed is MET; the disease is mesothelioma.